Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0029 | 1 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.0033 | 1 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0024 | 1 |
mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |